| 摘要: |
| 文章旨在分析澳大利亚仿制药价格披露制度，在研究其制度背景、历史沿革的基础上，采用描述性统计及典型案例分析法追踪价格披露全流程各步骤，探讨其制度绩效，为我国未来在新医改政策有效推行的前提下构建市场因素起主导地位的仿制药定价调价体系提供了借鉴意义。 |
| 关键词: |
| DOI： |
|
| 基金项目: |
|
| A study of Price Disclosure among genetic medicines in Australia |
|
| () |
| Abstract: |
| This paper aims to analysis the Price Disclosure system of genetic drugs in Australia. After studying the background and historical evolution，the paper track each step of Price Disclosure on the basis of descriptive statistics and analysis in order to provide reference for our country under the health care reform and achieve remarkable success. |
| Key words: |
